Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Germline-sequence variants S836S and L769L in the RE arranged during Transfection (RET) proto-oncogene are not associated with predisposition to sporadic medullary carcinoma in the French population.

Berard I, Kraimps JL, Savagner F, Murat A, Renaudin K, Nicolli-Sire P, Bertrand G, Moisan JP, Bezieau S.

Clin Genet. 2004 Feb;65(2):150-2. No abstract available.

PMID:
14984475
2.

Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.

Ruiz A, Antiñolo G, Fernández RM, Eng C, Marcos I, Borrego S.

Clin Endocrinol (Oxf). 2001 Sep;55(3):399-402.

PMID:
11589684
3.

[G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients].

Wohllk G N, Soto C E, Bravo A M, Becker C P.

Rev Med Chil. 2005 Apr;133(4):397-402. Epub 2005 Jun 8. Spanish.

4.
5.

[Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma].

Musholt PB, Musholt TJ, Moley JF, Scheumann GF.

Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):261-5. German.

PMID:
14518256
6.

RET activation in medullary carcinomas.

Pierotti MA, Arighi E, Degl'innocenti D, Borrello MG.

Cancer Treat Res. 2004;122:389-415. Review. No abstract available.

PMID:
16209058
7.

[RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].

Severskaia NV, Saenko VA, Il'in AA, Chebotareva IV, Rumiantsev PO, Isaev PA, Medvedev VS, Iasmita S.

Mol Biol (Mosk). 2006 May-Jun;40(3):425-35. Russian.

PMID:
16813162
8.

A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule.

Maschek W, Pichler R, Rieger R, Weinhäusel A, Berg J.

Clin Endocrinol (Oxf). 2002 Jun;56(6):823. No abstract available.

PMID:
12072055
9.

RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.

Wiench M, Włoch J, Wygoda Z, Gubała E, Oczko M, Pawlaczek A, Kula D, Lange D, Jarzab B.

Cancer Detect Prev. 2004;28(4):231-6.

PMID:
15350625
10.

Does a somatic deletion in RET clarify the sporadic nature of medullary thyroid carcinoma?

Gimm O, Marsh DJ.

J Endocrinol Invest. 2003 Apr;26(4):381-3. No abstract available.

PMID:
12841548
11.

Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.

Marsh DJ, Andrew SD, Learoyd DL, Pojer R, Eng C, Robinson BG.

Hum Mutat. 1998;Suppl 1:S3-4. No abstract available.

PMID:
9452023
12.

Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.

Machens A, Frank-Raue K, Lorenz K, Rondot S, Raue F, Dralle H.

Clin Endocrinol (Oxf). 2012 May;76(5):691-7. doi: 10.1111/j.1365-2265.2011.04293.x.

PMID:
22111543
13.

The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.

Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL.

Endocr Relat Cancer. 2010 Oct 5;17(4):953-63. doi: 10.1677/ERC-09-0312. Print 2010 Dec.

14.

Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.

Wiench M, Wygoda Z, Gubala E, Wloch J, Lisowska K, Krassowski J, Scieglinska D, Fiszer-Kierzkowska A, Lange D, Kula D, Zeman M, Roskosz J, Kukulska A, Krawczyk Z, Jarzab B.

J Clin Oncol. 2001 Mar 1;19(5):1374-80.

PMID:
11230481
15.

A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.

Demeester R, Parma J, Cochaux P, Vassart G, Abramowicz MJ.

Hum Mutat. 2001 Apr;17(4):354. No abstract available.

PMID:
11295841
16.

The frequency of selected polymorphic variants of the RET gene in patients with medullary thyroid carcinoma and in the general population of central Poland.

Sromek M, Czetwertyńska M, Skasko E, Zielińska J, Czapczak D, Steffen J.

Endocr Pathol. 2010 Sep;21(3):178-85. doi: 10.1007/s12022-010-9125-8.

PMID:
20521125
17.

[Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].

Fitze G, Saeger HD, Roesner D, Schackert HK.

Klin Padiatr. 2004 Sep-Oct;216(5):270-6. German.

PMID:
15455293
18.

Surgical treatment of medullary carcinoma of the thyroid.

Favia G, Lumachi F.

Tumori. 2001 Jul-Aug;87(4):S49-51. No abstract available.

PMID:
11693822
19.

Medullary thyroid carcinoma. Genetic screening and prophylactic thyroidectomies.

Bergant D, Hocevar M.

Acta Chir Iugosl. 2003;50(3):121-4.

PMID:
15179767
20.

Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer.

Borrego S, Fernández RM, Dziema H, Japón MA, Marcos I, Eng C, Antiñolo G.

Thyroid. 2002 Nov;12(11):1017-22.

PMID:
12490080

Supplemental Content

Support Center